Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant Treatment of Cervical Cancer
Clinical trial NCT06986057 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06986057
- Sponsor
- Shandong Tumor Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-31
- Primary completion
- 2026-07-31
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.